An Act To Dedicate a Portion of the Tax on the Sale of Marijuana to Substance Abuse Prevention and Treatment, Law Enforcement Costs and Regulatory Oversight
Sec. 1. 5 MRSA §20067, sub-§1-A, as amended by PL 2011, c. 657, Pt. AA, §45, is further amended to read:
Sec. 2. 5 MRSA §20068 is enacted to read:
§ 20068. Substance Abuse Education, Prevention and Treatment Fund
Sec. 3. 36 MRSA §1817, sub-§2, as enacted by IB 2015, c. 5, §3, is amended to read:
Sec. 4. 36 MRSA §1817, sub-§7, as enacted by IB 2015, c. 5, §3, is repealed and the following enacted in its place:
Sec. 5. 36 MRSA §§1818 and 1819 are enacted to read:
§ 1818. Tax on the sale of medical marijuana
§ 1819. Wholesale tax on marijuana
Sec. 6. Effective date. This Act takes effect February 1, 2018.
summary
This bill establishes the Substance Abuse Education, Prevention and Treatment Fund to provide funding for:
1. Programs for education regarding prevention of and support and treatment for substance abuse, including the prevention of marijuana use by minors;
2. Regulatory oversight of the retail marijuana industry; and
3. Increased costs to law enforcement agencies and the courts associated with the retail marijuana industry.
The fund is administered by the Department of Health and Human Services and disbursed based on the recommendations of the Substance Abuse Services Commission.
The fund is funded by an increase in the tax imposed on the retail sale of marijuana and marijuana products from 10% to 15%, an increase on the tax imposed on medical marijuana from 5.5% to 15% and a wholesale tax imposed on the sale of marijuana and marijuana products for retail sale of 3%. Five percent of the revenue from these taxes is deposited in the Substance Abuse Education, Prevention and Treatment Fund; the balance is deposited in the General Fund.